While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.

Overregulation and the second-highest corporate tax rate in the country “have hurt job creators” and led to the state’s net ...

Medtronic (MDT) is back in focus after William Blair upgraded the stock to Outperform, highlighting new product ramps tied to ...

If you are wondering whether Medtronic's current share price still offers value, this article will walk through what that ...

Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.

William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers ...

Fintel reports that on January 6, 2026, William Blair upgraded their outlook for Medtronic (NYSE:MDT) from Market Perform to ...

Medtronic (MDT) is a strong defensive investment with stable growth, 49 years of dividend increases, and fair value. Read here for more analysis.

Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

This week's Medtech in a Minute features a significant robotics milestone for Johnson & Johnson and health tech trends you ...

As Cadillac continues to redefine luxury and electrification, Altia remains a committed technology partner—ready to support ...